Phase I study of gefitinib (G) + durvalumab (D) for locally advanced/metastatic non-small cell lung cancer (NSCLC) harbouring epidermal growth factor receptor (EGFR) sensitising mutations
Creelan, B.C., Yeh, T., Kim, S.-W., Nogami, N., Kim, D.-W., Chow, L.Q., Kanda, S., Taylor, R., Tang, W., Tang, M., Angell, H.K., Roudier, M.P., Marotti, M., Gibbons, D.L.
Published in Annals of oncology (01.04.2019)
Published in Annals of oncology (01.04.2019)
Get full text
Journal Article
Olaparib plus paclitaxel sensitivity in biomarker subgroups of gastric cancer
Liu, Y.-Z., Hodgson, D., Locker, G., Lai, Z., Balcerzak, D., Sharpe, A., Barrett, J.C., Orr, M., Gutjahr, T.S., Dougherty, B., Roudier, M.P., Shi, X., Miller, R., Kim, W.H., Zeng, X., Ochiai, A., Im, S.-A., Xu, R.-H., Boku, N., Bang, Y.-J.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
Metastatic conventional prostatic adenocarcinoma with diffuse chromogranin A and androgen receptor positivity
Roudier, M P, True, L D, Vessella, R L, Higano, C S
Published in Journal of clinical pathology (01.03.2004)
Published in Journal of clinical pathology (01.03.2004)
Get full text
Journal Article